Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

CA23204J1049
Filter zurücksetzen
Di., 03.11.2026
CA23204J1049

As a result of a review by the British Columbia Securities Commission, Custom Health is issuing the following press release to clarify its disclosure.Kelowna, British Columbia--(Newsfile Corp. - November 3, 2026) - Custom Health Holdings Inc. (TSX: CHLT) ("Custom Health" or the "Corporation") is pleased to announce that it has filed a prelimi...
Zur Nachricht
Permalink
Mi., 21.10.2026
CA23204J1049

Custom Health will close the market at the Toronto Stock Exchange on October 22, 2026, to celebrate the Company's recent listing on the TSX Exchange.Mike Palackdharry has been appointed Chief Commercial and Strategy Officer, bringing more than 30 years of experience in commercial strategy, enterprise sales, business development, and strategic partn...
Zur Nachricht
Permalink
Di., 20.10.2026
CA23204J1049

Custom Health's existing commercial program with BKC Pain Specialists & Regenerative Medicine Clinic in Ohio is demonstrating early results through the integration of in-home medication technology, pharmacy services and pharmacist-led clinical support for patients managing complex chronic pain.The program provides continuous visibility into pat...
Zur Nachricht
Permalink
Di., 08.09.2026
CA23204J1049

Effective September 4, 2026, Custom Health has completed its previously announced acquisition of Spencer Health Solutions, developer of the spencer® smart medication dispenser and in-home monitoring platform, giving the Company full ownership of the spencer® technology, intellectual property, and product roadmap.Spencer now operates as a...
Zur Nachricht
Permalink
Di., 18.08.2026
CA23204J1049

For the three months ended June 30, 2026, Custom Health achieved quarterly revenue of US$7.4 million, an increase of 70% from Q2-2025. The results reflect the acquisition of InnovativeRx during the period. The equity pickup for IRX accounts for an acquisition date of June 5, 2026. Proforma Revenue for the combined entity for the 3 months ended June...
Zur Nachricht
Permalink
Mi., 05.08.2026
CA23204J1049

Custom Health has entered into a definitive agreement to acquire Spencer Health Solutions, which is expected to unite Custom Health's pharmacist-led medication management platform with the spencer® in-home smart dispensing and monitoring system, bringing an important in-home medication technology capability fully in-house and further strengthe...
Zur Nachricht
Permalink
Mi., 22.07.2026
CA23204J1049

Custom Health has entered into a binding letter of intent (the "LOI") to acquire Evergreen Pharmacy LLC ("Evergreen"), a Wisconsin-based specialty pharmacy specializing in the management of complex therapies for chronic disease states.Evergreen generated Revenue of approximately US$78.8 million with Normalized EBITDA (1) of US$0.60 million, for the...
Zur Nachricht
Permalink
Fr., 03.07.2026
CA23204J1049

For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million, reflecting total consolidated quarterly revenue of US$12.9 million and proforma annualized revenue run-rate(1) of US$51.6 million.Custom Health successfully...
Zur Nachricht
Permalink
Do., 25.06.2026
CA23204J1049

Robert Guzman has been appointed Chief Compliance & Regulatory Officer, bringing extensive experience in regulatory oversight, compliance management, and quality assurance to strengthen Custom Health's governance framework and support the Company's continued expansion across highly regulated healthcare and pharmacy markets.Brent Herman, Founder...
Zur Nachricht
Permalink